Eulerpool Terminal
The edge that pays for itself.
Current Cannara Biotech forecasts and price targets in August 2026
Ø Analyst Price Targets
3.57 CAD
+84.97 %
Median
3.57 CAD
+84.97 %
Max
3.68 CAD
Min
3.54 CAD
Last Price
1.93 CAD
Buy
4
Hold
1
Sell
0
The average target price for Cannara Biotech is 3.57 CAD. (+84.97 % above the current price)
The median price target of Cannara Biotech is 3.57 CAD.
Stock analysts from many renowned investment banks are closely examining the Cannara Biotech stock. They conclude their professional Cannara Biotech stock analyses with a clear recommendation for the Cannara Biotech stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 4 | 1 | 0 | 3.57 CAD |
| 2026-01-01 | 4 | 1 | 0 | 3.57 CAD |
| 2025-12-01 | 4 | 1 | 0 | 3.57 CAD |
| 2025-12-01 | 4 | 1 | 0 | 3.57 CAD |
| 2025-11-01 | 4 | 1 | 0 | 3.06 CAD |
| 2025-11-01 | 4 | 1 | 0 | 3.06 CAD |
Cannara Biotech Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Cannara Biotech in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 129.00 M CAD | 15.00 M CAD | 0.16 CAD |
| 2027e | 140.00 M CAD | 19.00 M CAD | 0.21 CAD |
| 2028e | 172.00 M CAD | 25.00 M CAD | 0.27 CAD |